comparemela.com

Latest Breaking News On - Carsgen therapeutics - Page 4 : comparemela.com

CARsgen Appoints Dr Sylvie Peltier as Senior Vice President of Global Regulatory Affairs

/PRNewswire/ CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on innovative CAR T-cell therapies for the treatment of.

France generalRaffaele baffaSylvie peltierUs regulatory affairs at morphosys incPharmaceuticals industries ltdEurope regulatory affairsPrnewswire carsgen therapeutics holdings limited stock codeHealth lawUs regulatory affairsPfizer regulatory affairsServier pharmaceuticalsUniversity of parisGlobal regulatory affairs of the companyHead of regulatory affairs at servier pharmaceuticalsGlobal regulatory affairsTherapeutics holdings limited

CARsgen 2022 Interim Results: Innovative CAR T-cell Technologies and Robust Pipeline

/PRNewswire/ CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on innovative CAR T-cell therapies for the treatment of.

United statesNorth carolinaResearch triangle parkRaffaele baffaZonghai liRichard dalyManufacturing facility in research triangle parkAmerican society of clinical oncologyCarsgen therapeutics holdingsCarsgen therapeutics holdings limited stock codeCarsgen therapeutics corporationInspections department of durhamEuropean medicines agencyTherapeutics holdings limitedStock codeChina investigator initiated trial

Case Report of Long Term Complete Response in Hepatocellular Carcinoma to CARsgen s GPC3 CAR T Cells (CT011) Published in Frontiers in Immunology

/PRNewswire/ CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on innovative CAR T-cell therapies for the treatment of.

Zonghai liFirst affiliated hospital of wenzhou medical universityCarsgen therapeutics holdingsPrnewswire carsgen therapeutics holdings limited stock codeTherapeutics holdings limitedStock codeTerm complete responseAdvanced hepatocellular carcinomaChimeric antigen receptort cellsFirst affiliated hospitalWenzhou medicalChief executive officerChief scientific officerTherapeutics holdingsCarsgen therapeutics

CARsgen Appoints Dr Raffaele Baffa as Chief Medical Officer

/PRNewswire/ CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on innovative CAR T cell therapies for the treatment of.

United statesRaffaele baffaZonghai liSchool of medicineCarsgen therapeutics holdingsUniversity of parmaUniversity of padovaChief executive officerChief scientific officerTherapeutics holdings limitedNorth americaChief medical officerCarsgen therapeutics

CARsgen Announces First Patient Enrollment in the Confirmatory Phase II Clinical Trial of CT041 in China

/PRNewswire/ CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on innovative CAR T cell therapies for the treatment of.

United statesCarsgen therapeutics holdingsHealth canadaOrphan drugOrphan medicinal productRegenerative medicine advanced therapyNorth americaTherapeutics holdingsCarsgen therapeutics

vimarsana © 2020. All Rights Reserved.